TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.3204
+0.0025 (0.79%)
At close: Sep 11, 2026, 4:00 PM EDT
0.3202
-0.0002 (-0.06%)
After-hours: Sep 11, 2026, 6:27 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $21.72 million as of September 11, 2026. Its market cap has decreased by -79.20% in one year.
Market Cap
21.72M
Enterprise Value
12.45M
1-Year Change
-79.20%
Ranking
Category
Stock Price
$0.32
ChartMarket Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $21.72M, a decrease of -93.95%. That is a compound annual growth rate of -41.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 21.72M | -61.73% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 23.95M |
| Cocrystal Pharma | 23.89M |
| NanoViricides | 23.69M |
| Jasper Therapeutics | 23.33M |
| Lantern Pharma | 22.63M |
| Polyrizon | 22.62M |
| Cellectar Biosciences | 22.35M |
| GridAI Technologies | 21.38M |